Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings

Despite mass drug administration programmes with praziquantel, the prevalence of schistosomiasis remains high. A vaccine is urgently needed to control transmission of this debilitating disease. As some promising schistosomiasis vaccine candidates are moving through pre-clinical and clinical testing,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Immunol
Egile Nagusiak: Driciru, Emmanuella, Koopman, Jan Pieter R., Cose, Stephen, Siddiqui, Afzal A., Yazdanbakhsh, Maria, Elliott, Alison M., Roestenberg, Meta
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2021
Gaiak:
Immunology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7970007/
https://ncbi.nlm.nih.gov/pubmed/33746974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.635985
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak